Occlutech AFR Heart Failure Device Obtains CE Mark Approval
SCHAFFHAUSEN, Switzerland, Sept. 6, 2019 /PRNewswire-AsiaNet / -- Occlutech AG announced today that its atrial flow regulator, the Occlutech AFR device, has obtained CE mark approval clearing it for sales on the European CE regulated market. Occlutech AFR is a next generation intra-atrial shunt device, intended ...
Authors: LATEST ASIANET NEWS RELEASES